Skip to content

Nebulized Dexmedetomidine, Ketamine, or Midazolam in Children Undergoing Adenotonsillectomy

Comparison of Nebulized Dexmedetomidine, Ketamine, or Midazolam for Premedication in Children Undergoing Adenotonsillectomy

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07564037
Enrollment
60
Registered
2026-05-04
Start date
2024-11-30
Completion date
2025-12-30
Last updated
2026-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adenotonsillectomy, Children, Dexmedetomidine, Midazolam

Keywords

Midazolam, Nebulized, Dexmedetomidine, Adenotonsillectomy, Children

Brief summary

The aim of this study is to compare between nebulized dexmedetomidine, ketamine, or midazolam for premedication in children undergoing adenotonsillectomy.

Detailed description

The aim of this study is to compare between nebulized dexmedetomidine, ketamine, or midazolam for premedication in children undergoing adenotonsillectomy. Primary outcome: • A five-point sedation score on arrival in the operating room 30 min after drug administration. Secondary outcomes: * Parental separation anxiety scale. * Medication and mask acceptance scales. * Hemodynamic variables. * Recovery time. * Postoperative face, legs, activity, cry, and consolability (FLACC) scale. * Emergence Agitation scale. * Adverse effects.

Interventions

DRUGGroup K:nebulized ketamine group

Patients will receive nebulized ketamine 2 mg kg -1

DRUGGroup D:dexmedetomidine group

Patients will receive dexmedetomidine 2 mcg kg -1

DRUGGroup M: midazolam group

Patients will receive midazolam 0.2 mg kg -1

Sponsors

Tanta University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
3 Years to 7 Years
Healthy volunteers
No

Inclusion criteria

* Children aged between 3-7 years. * Both sexes. * American society of anesthesiologists (ASA) physical status (I-II). * Children undergoing adenotonsillectomy.

Exclusion criteria

* Patients with known allergy to the study drugs. * Significant organ dysfunction. * Cardiac dysrhythmia. * Congenital heart disease. * Use of psychotropic medication, and mental retardation

Design outcomes

Primary

MeasureTime frameDescription
A five-point sedation score on arrival in the operating room30 min after drug administrationSedation level will be assessed at the same time points mentioned above using a five-point sedation scale score as follows: 1= agitated, 2= alert, 3= calm, 4= drowsy, and 5=asleep . A score ≥ 3 will be considered as acceptable sedation.

Secondary

MeasureTime frameDescription
Parental separation anxiety scale2 hoursparental separation will be assessed by a four-point parental separation anxiety scale (PSAS) as follows: 1= easy separation, 2= whimpers, but is easily reassured, not clinging, 3= cries and cannot be easily reassured, but not clinging to parents, and 4= crying and clinging to parents. PSAS scores of 1 and 2 signified acceptable separation whereas scores of 3 and 4 will be classified as difficult separation .

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 8, 2026